Co-Diagnostics, Inc. Payments to Acquire Interest in Joint Venture
Co-Diagnostics, Inc. (CODX) reported Payments to Acquire Interest in Joint Venture of $102.57 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInJointVenture · last filed 2026-03-31
- Co-Diagnostics, Inc. payments to acquire interest in joint venture for the quarter ending 2024-12-31 was $0.00.
- Co-Diagnostics, Inc. payments to acquire interest in joint venture for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- Co-Diagnostics, Inc. payments to acquire interest in joint venture for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Co-Diagnostics, Inc. payments to acquire interest in joint venture for the quarter ending 2020-06-30 was $564.50K, a 222.57% increase year-over-year.
- Co-Diagnostics, Inc. payments to acquire interest in joint venture for fiscal 2025 was $102.57K, a 28.65% decline from fiscal 2024.
- Co-Diagnostics, Inc. payments to acquire interest in joint venture for fiscal 2024 was $143.75K.
- Co-Diagnostics, Inc. payments to acquire interest in joint venture for fiscal 2020 was $714.50K, a 121.89% increase from fiscal 2019.
- Co-Diagnostics, Inc. payments to acquire interest in joint venture for fiscal 2019 was $322.00K, a 5.01% decline from fiscal 2018.
| Period end | Payments to Acquire Interest in Joint Venture 3 month | Payments to Acquire Interest in Joint Venture 6 month | Payments to Acquire Interest in Joint Venture 9 month | Payments to Acquire Interest in Joint Venture 12 month |
|---|---|---|---|---|
| 2025-12-31 | $102.57K 10-K · filed 2026-03-31 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $143.75K 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $143.75K 10-Q · filed 2025-11-13 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $564.50K derived: sum of 3 quarters · filed 2021-03-25 | $714.50K 10-K · filed 2021-03-25 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | $564.50K derived: sum of 2 quarters · filed 2020-11-16 | $714.50K 10-Q · filed 2020-11-16 | $717.06K derived: sum of 4 quarters · filed 2021-03-25 |
| 2020-06-30 | $564.50K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03 | $714.50K 10-Q/A · filed 2020-11-03 | $717.06K derived: sum of 3 quarters · filed 2021-03-25 | $789.50K derived: sum of 4 quarters · filed 2021-03-25 |
| 2020-03-31 | $150.00K 10-Q · filed 2020-05-14 | $152.56K derived: sum of 2 quarters · filed 2021-03-25 | $225.00K derived: sum of 3 quarters · filed 2021-03-25 | $400.00K derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-12-31 | $2.56K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $75.00K derived: sum of 2 quarters · filed 2021-03-25 | $250.00K derived: sum of 3 quarters · filed 2021-03-25 | $322.00K 10-K · filed 2021-03-25 |
| 2019-09-30 | $72.44K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | $247.44K derived: sum of 2 quarters · filed 2020-11-16 | $319.44K 10-Q · filed 2020-11-16 | $523.44K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $175.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03 | $247.00K 10-Q/A · filed 2020-11-03 | $451.00K derived: sum of 3 quarters · filed 2020-11-03 | $526.00K derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-03-31 | $72.00K 10-Q · filed 2020-05-14 | $276.00K derived: sum of 2 quarters · filed 2020-05-14 | $351.00K derived: sum of 3 quarters · filed 2020-05-14 | $396.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $279.00K derived: sum of 2 quarters · filed 2020-03-30 | $324.00K derived: sum of 3 quarters · filed 2020-03-30 | $339.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $75.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $120.00K derived: sum of 2 quarters · filed 2019-11-12 | $135.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $60.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $15.00K 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | $60.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |